-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Shijiazhuang Sihua Pharmaceutical Group’s Bosheng Medical Devices Has Consecutively Received “Four” Corporate Honors
Category:
发布时间：2024-02-22
【概要描述】
Recently, the CPC Xinghua Municipal Committee and the Xinghua Municipal People’s Government convened a citywide conference to recognize and commend high-quality industrial development, honoring outstanding entrepreneurs with awards, inspiring more entrepreneurs through such recognition, and sounding the “New Year’s battle drum” for high-quality industrial development. The goal is to foster a widespread culture of “enterprises daring to act” across Xinghua, making bold initiative the defining posture of Xinghua enterprises as they set sail for new growth in the new era.
Recently, the CPC Xinghua Municipal Committee and the Xinghua Municipal People’s Government convened a citywide conference to recognize and commend high-quality industrial development, honoring outstanding entrepreneurs with awards, inspiring more entrepreneurs through recognition, and sounding the “New Year’s battle drum” for high-quality industrial growth. The goal is to foster a widespread culture of bold enterprise in Xinghua, making “daring to act” the defining ethos of Xinghua’s businesses as they set sail for new heights of development in the new era.
At the conference, the Xinghua Municipal Party Committee and Municipal Government commended a number of outstanding enterprises and model projects for their remarkable contributions. Shijiazhuang Sihua Pharmaceutical Group Jiangsu Bosheng Medical New Materials Co., Ltd. was honored with four prestigious awards for 2023: “Outstanding Taxpayer,” “Top Ten Enterprises in Technological Innovation,” “Outstanding Import-Export Enterprise,” and “Outstanding Enterprise in Employment and Entrepreneurship.”
Jiangsu Bosheng Medical New Materials Co., Ltd. is a subsidiary of Shijiazhuang Sihua Pharmaceutical Group, a company listed on the National Equities Exchange and Quotations (NEEQ), a national high-tech enterprise, a recipient of the National Torch Program, and the undertaking entity for both the National Key New Product program and the National Manufacturing Single-Champion Product initiative. In recent years, Bosheng Medical has remained focused on its core business, continuously advancing new-product R&D and technological upgrades. Leveraging its robust R&D capabilities and stringent quality-assurance system, the company provides safe and reliable pharmaceutical packaging materials to customers both domestically and internationally, while fostering close strategic partnerships. In 2023, guided by innovation-driven development, Bosheng Medical deepened its expertise in the manufacturing of high-precision, cutting-edge medical packaging materials, adopting a development approach centered on “expanding product variety, elevating performance levels, and enhancing quality and efficiency.” The company has prioritized fundamental, innovative, and forward-looking research on rubber stoppers, co-extruded films, and emerging medical packaging materials, steadily moving toward its goal of becoming an innovative pharmaceutical packaging enterprise. A series of advanced process technologies and high-quality formulated products developed in-house—including non-PVC infusion films, coated rubber stoppers, laminated rubber stoppers, and no-wash halogenated butyl rubber stoppers—have earned widespread acclaim across the industry. Meanwhile, the company has also pioneered the domestic development of multi-layer co-extruded bio-grade films for single-use systems, whose overall performance rivals that of imported counterparts.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091